5Zulia Wang,Zhaohui Ge,Dong Wei,et al.Treatment of spinaltuberculosis with ultrashort-course chemotherapy in con-junction with partial excision of pathologic vertebrae[J].TheSpine Journal,2007,7:671-681.
6A Umubyeyi,L Rigoutsb,IC Shamputa,et al.Low levels ofsecond line drug resistance among multidrug resistant Myco-bacterium tuberculosis isolates from Rwanda[J].Internation-al Journal of Infectious Diseases,2008,12:152-156.
9Murugesan D,Palaniappan S,Perumal Y,et al.Novel ofloxa-cin derivatives:Synthesis,antimycobacterial and toxicologicalevaluation[J].Bioorg Med Chem Lett,2008,18:1229-1236.
10Maria VP,William DB,Michael RM.NLCQ-1 and NLCQ-2,two new agents with activity against dormant Mycobacte-rium tuberculosis[J].Int J Antimicrob Agents,2007,29:724-727.
9Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migliori GB, Bade J, Kochi A, Dye C, Raviglione MC. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries[J]. JAMA, 2000, 283(19): 2537-2545.
10Ohkado A, Aguiman L, Adlawan S, Baring E, Quirante O, Su- chi M, Endo, S, Fujiki A, Mori T. Tuberculosis drug-resist- ance and treatment outcomes under DOTS settings in large city in the Philippines[J]. Int J Tuberc Lung Dis, 2006,10:283- 289.
